GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 172   

Articles published

GSK 45.97 -0.32 (-0.69%)
price chart
Melanoma Treatment Battle Between Roche And GSK Heats Up
Roche Holding Ltd. (ADR) (RHHBY) and GlaxoSmithKline Plc (GSK) separately announced positive results for their respective combination therapies used for the treatment of melanoma, in the European Society of Medical Oncology conference (ESMO) in ...
Related articles »  
Thermo Fisher Teams Up With GSK, Pfizer To Develop NGS Oncology ...
Thermo Fischer Scientific Inc. (TMO) announced yesterday, a collaborative agreement with Pfizer Inc. (PFE) and GlaxoSmithKline Plc ADR (GSK) for the development of a next-generation sequencing (NGS) technique which is an oncology diagnostic test for ...
Related articles »  
Novartis Wins The Battle Over Bronchodilators Against GSK
Novartis AG ADR (NVS) reported yesterday that its once-daily Ultibro (Breezhaler) bronchodilator outperformed GlaxoSmithKline plc's (ADR) (GSK) twice-daily blockbuster Seretide (Accuhaler) bronchodilator in Phase-III trials. The results of the Phase ...
Related articles »  
GSK Facing Multimillion Dollar Settlement Or Fines Because Of US Probe
GlaxoSmithKline plc (ADR) (GSK) is back once again in the negative spotlight as details have emerged that a US anti-bribery probe touched upon the firm's Chinese consumer healthcare business in 2012, for possible violations of anti-bribery laws.
Related articles »  
WHO Assures Sufficient Doses Of Ebola Vaccines By Year-End
GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ) and NewLink Genetics Corp (NLNK) are working on vaccines for the prevention of the Ebola virus, which broke out in December last year.
Inovio Pharmaceuticals Inc (NASDAQ:INO) To Advance Development Of Ebola ...  WallStreetPR
Related articles »  
3 Oversold Stocks You Should Be Buying [GlaxoSmithKline plc (ADR), Whole ...
buy-now Marshall Hargrave: The summer brought a number of major selloffs among top stocks, which have led to great buying opportunities.
GSK Will Not Be Able To Complete Its Flu Vaccine Order For Canada
GlaxoSmithKline plc (ADR) (GSK), Canada's largest flu vaccine supplier, announced on September 4 that it will not be able to fulfill 30% of its promised flu vaccine order for the 2014-15 flu season.
Related articles »  
GSK China Fined $490 Million For Bribery
GlaxoSmithKline plc's (ADR) (GSK) Chinese subsidiary, GSK China Investment Co. Ltd., has been found guilty by Chinese Courts of bribing doctors to increase sales of its Consumer Health business.
GlaxoSmithKline plc (ADR) (GSK) Faces Fines Worth $489 Million, Former Head ...  StockWise Daily
GlaxoSmithKline plc (ADR) (NYSE:GSK) Earns $500 Million Slap In China  WallStreetPR
Related articles »  
Ebola Aid Being Flown To Affected Areas
Previous donations were made by corporations like Johnson & Johnson (JNJ), GlaxoSmithKline plc (ADR) (GSK), Merck & Co.
Are Vaccines The Solution For Ebola?
The Ebola outbreak in West Africa has changed from an epidemic to much more: the World Health Organization (WHO) has declared it a public health emergency, while the UN Security Council has called the virus a global security threat.
Related articles »